Literature DB >> 2299228

In vivo 31P-NMR spectroscopy of murine tumours before and after localized hyperthermia.

P Vaupel1, P Okunieff, L J Neuringer.   

Abstract

In vivo 31P-NMR spectroscopy was used to monitor the energy metabolism, apparent intracellular pH (pHNMR), and phospholipid turnover in subcutaneous fibrosarcomas (FSall) and mammary carcinomas (MCaIV) treated with hyperthermia (HT). Treatment consisted of elevation of tumour temperature to 43.5 degrees C for 15, 30 or 60 min (FSall) and 30 min (MCaIV). Experiments were performed on conscious mice with biologically relevant tumour sizes. Using water bath immersion, this study focused on acute heat-induced metabolic changes (up to 7 h post-HT). 31P-NMR spectra of both murine tumours were characterized by relatively high pretreatment levels of PME, Pi and NTP, and lower levels of PDE, PCr and DPDE. Following hyperthermia, NTP and PCr levels, as well as pHNMR, decreased in both tumour lines. This drop was accompanied by a prompt and dramatic increase in Pi. After heating for 15 min, the limited spectral changes observed for the high-energy phosphates and the marginal decline in pHNMR were nullified within 7 h, whereas Pi remained significantly elevated. With the exception of PME/NTP and PME/PDE, all relevant metabolic ratios (PCr/Pi, NTP/Pi, PME/Pi) decreased after heating and did not resolve thereafter. Upon longer heat exposure times the high-energy phosphates, pHNMR, NTP/Pi, PCr/Pi, and PME/Pi all decreased in a dose-dependent manner and remained at the respective lower levels. The PME/PDE ratio was increased after 43.5 degrees C/15 min whereas at longer heating times this ratio did not change. At comparable heat doses MCaIV tumours seem to exhibit changes similar to FSall tumours.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2299228     DOI: 10.3109/02656739009140801

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  7 in total

Review 1.  Utility of functional imaging in prediction or assessment of treatment response and prognosis following thermotherapy.

Authors:  Mark W Dewhirst; Donald E Thrall; Gregory Palmer; Thies Schroeder; Zeljko Vujaskovic; H Cecil Charles; James Macfall; Terence Wong
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

Review 2.  Cancer insights from magnetic resonance spectroscopy of cells and excised tumors.

Authors:  Marie-France Penet; Raj Kumar Sharma; Santosh Bharti; Noriko Mori; Dmitri Artemov; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2022-03-09       Impact factor: 4.478

Review 3.  Accumulation of purine catabolites in solid tumors exposed to therapeutic hyperthermia.

Authors:  M Busse; P Vaupel
Journal:  Experientia       Date:  1996-05-15

4.  Microregional distributions of glucose, lactate, ATP and tissue pH in experimental tumours upon local hyperthermia and/or hyperglycaemia.

Authors:  C Schaefer; W K Mayer; W Krüger; P Vaupel
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results.

Authors:  Caecilia Wismeth; Christine Dudel; Christina Pascher; Paul Ramm; Torsten Pietsch; Birgit Hirschmann; Christiane Reinert; Martin Proescholdt; Petra Rümmele; Gerhard Schuierer; Ulrich Bogdahn; Peter Hau
Journal:  J Neurooncol       Date:  2009-12-24       Impact factor: 4.130

6.  The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour model.

Authors:  M Nordsmark; R J Maxwell; M R Horsman; S M Bentzen; J Overgaard
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply.

Authors:  H Lyng; D R Olsen; T E Southon; E K Rofstad
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.